• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IN2BONES SAS QUANTUM; QUANTUM® TIBIAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IN2BONES SAS QUANTUM; QUANTUM® TIBIAL IMPLANT Back to Search Results
Device Problems Failure to Osseointegrate (1863); Migration (4003)
Patient Problems Pain (1994); Arthralgia (2355); Ambulation Difficulties (2544); Implant Pain (4561)
Event Date 12/13/2022
Event Type  Injury  
Manufacturer Narrative
Investigations are in progress.A complete and final mdr report will be submitted when all investigations are performed.
 
Event Description
The quantum® total ankle prosthesis is indicated as a total ankle replacement in primary or revision surgery for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis.The quantum® total ankle prosthesis is a fixed-bearing, semi-constraint ankle prothesis with 2 components and composed of: - a tibial component composed of a metallic (ta6v) tibial tray implant fixed to a polymer (uhwmpe) insert, - a metallic (cocr) talar implant reproducing the talus dome anatomy.When all components are implanted, with the insert rigidly locked to the tibial tray, the polyethylene insert acts as a single bearing along the talar dome, enabling flexion/extension and rotation movement at the replaced ankle joint.Each component of the quantum® total ankle prosthesis exists in different sizes and models.Event description: one surgeon based in belgium reported 4 cases of lucency (border on xrays) around the tibial component associated to pain for 4 of his patients (2 of them might need a revision surgery later):.Patient number 12 = lucency with pain reported 1 year post-operative;.Patient number 14 = lucency with pain reported 6 months post-operative;.Patient number 16 = lucency with pain reported 6 months post-operative;.Patient number 17 = lucency with pain reported 4 months post-operative.Additional information are to be collected and investigations are in progress.
 
Event Description
The quantum® total ankle prosthesis is indicated as a total ankle replacement in primary or revision surgery for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis.The quantum® total ankle prosthesis is a fixed-bearing, semi-constraint ankle prothesis with 2 components and composed of: a tibial component composed of a metallic (ta6v) tibial tray implant fixed to a polymer (uhwmpe) insert, a metallic (cocr) talar implant reproducing the talus dome anatomy.When all components are implanted, with the insert rigidly locked to the tibial tray, the polyethylene insert acts as a single bearing along the talar dome, enabling flexion/extension and rotation movement at the replaced ankle joint.Each component of the quantum® total ankle prosthesis exists in different sizes and models.Event description : one surgeon based in belgium reported 4 cases of lucency (border on xrays) around the tibial component associated to pain for 4 of his patients (2 of them might need a revision surgery later): patient number: 12 = lucency with pain reported 1 year post-operative; patient number: 14 = lucency with pain reported 6 months post-operative; patient number: 16 = lucency with pain reported 6 months post-operative; patient number: 17 = lucency with pain reported 4 months post-operative.Additional information communicated by the surgeon: for patient 12 = information communicated during meeting on (b)(6) 2023: the significant lucency reported for patient 12 might have been induced by a user error during the initial surgery (10° of valgus induced by error when using the psi).For patient 14 = information communicated during meeting on (b)(6) 2023: young patient, very active, that had an active reeducation.The patient had an infiltration for pain management and will be closely monitored.A small artifact seems to be present around the tibial implant.Addition information received by in2bones on march 2nd, 2023 (e-mail): the patient has been reviewed by the surgeon (9 months post-operative), it seems that a small fragment of coating has been detached from the tibial implant.For patient 16 = information communicated during meeting on (b)(6) 2023: this patient also has an important tibial periosteal reaction, and the tibial implant lucency is associated to a tilt of the tibial implant.This patient is closely monitored and might need a revision surgery.Additional information communicated during meeting on (b)(6) 2023 : a revision surgery is being planned for this patient.For patient 17 = information communicated during meeting on (b)(6) 2023: for this patient, the lucency might be related to an insufficient impaction of the tibial implant intra-operatively.This patient has osteoporotic bones.A revision surgery might be required for this patient at a later date.Additional information communicated during meeting on (b)(6) 2023 : a revision surgery is being planned for this patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTUM
Type of Device
QUANTUM® TIBIAL IMPLANT
Manufacturer (Section D)
IN2BONES SAS
28 chemin du petit bois
batiment 2
ecully, 69130
FR  69130
Manufacturer (Section G)
IN2BONES SAS
28 chemin du petit bois
batiment 2
ecully, 69130
FR   69130
Manufacturer Contact
sabina ahaddad
28 chemin du petit bois
batiment 2
ecully, 69130
FR   69130
MDR Report Key17798265
MDR Text Key324029628
Report Number3010470577-2022-12071
Device Sequence Number1
Product Code HSN
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K191380
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-